The Companion Diagnostics Development Services Market

In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise



 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Companion Diagnostics Development Services Market, 2020-2030”

 

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of diagnostic development services over the next decade. It features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain. In addition to other elements, the study includes:

§  A detailed assessment of the current market landscape of more than 180 companies offering companion diagnostics services.

§  Tabulated profiles of companion diagnostics service providers (shortlisted on the basis of the number of services offered).

§  An analysis of the partnerships that have been established in this domain, in the recent past.

§  A list of stakeholders generated based on a detailed analysis of a set of relevant parameters, which are anticipated to partner with companion diagnostics services providers in the foreseen future.

§  A detailed competitiveness analysis of companion diagnostics services providers, featuring insightful pictorial summaries and representations.

§  A comparative analysis of the needs of different stakeholders involved in this domain.

§  A discussion on various steps of the development operations of a companion diagnostic and the cost requirements across each of the stages.

§  An analysis of completed, ongoing and planned clinical trials featuring disease-specific biomarkers.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Type of Services

§  Feasibility Studies

§  Assay Development

§  Analytical Validation

§  Clinical Validation

§  Manufacturing

§  Type of Analytical Technique

§  in situ hybridization / Immunohistochemistry

§  Next Generation Sequencing

§  Polymerase Chain Reaction

§  Others

§  Key Geographical Region 

§  North America

§  Europe

§  Asia-Pacific and the Rest of the World 

 

 

Transcripts of interviews held with the following senior level representatives of stakeholder companies

§  Anton Iliuk (President, Chief Technology Officer Tymora Analytical Operations)

§  Paul Kortschak (Senior Vice President, Novodiax)

§  Pablo Ortiz (Chief Executive Officer, OWL Metabolomics)

§  Lawrence M. Weiss (Chief Scientific Officer, NeoGenomics Laboratories)

 

 

Key companies covered in the https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html

 

§  Almac Diagnostic Services

§  Asuragen

§  BARD1 Life Sciences

§  BioMarCare Technologies

§  Covance

§  Gencurix

§  Geneuity

§  Leica Biosystems

§  Macrogen

§  MD Biosciences

§  R-Biopharm

§  ResearchDx

§  Tepnel Pharma Services

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html

 

Other Recent Offerings

1.     Neoantigen Targeted Therapies Market, 2019-2030

2.     Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030

3.     Global Stem Cells Market: Focus on Clinical Therapies, 2020-2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/

Comments

Post a Comment

Popular posts from this blog

The contract manufacturing market for Pharmaceuticals in China

Image
Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world   Roots Analysis is pleased to announce the publication of its recent study, titled, “ China Pharmaceutical Contract Manufacturing Services Market, 2020-2030 . ”   The report features an extensive study of the current market landscape and future opportunities associated with the pharmaceutical contract manufacturing market in China. The study also features a detailed analysis, highlighting the capabilities of pharmaceutical CMOs in this region. Amongst other elements, the report features: §   A detailed assessment of the current market landscape of pharmaceutical contract manufacturers in China engaged in the development of active pharmaceutical ingredients (APIs), intermediates and finished dosage formulations (FDFs).  §   A...
Read more

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

Image
  To order this detailed 350+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html   Key Inclusions §   A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms of action (inhibitory or stimulatory),  type of therapeutic modality used (monoclonal antibody, antibody fragment, small molecule and others), route of administration (intravenous, subcutaneous, oral and others), target disease indication, target therapeutic area and type of therapy (monotherapy, combination therapy and both).  §   A detailed analysis of more than 590 completed, ongoing and planned clinical studies of next generation immune checkpoint inhibitors and stimulators, highlighting prevalent trends across various relevant p...
Read more

Polycystic Ovary Syndrome Market, 2021-2031 by Roots Analysis

Image
Polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors   London   Roots Analysis has announced the addition of “ Polycystic Ovary Syndrome Market, 2021-2031 ” report to its list of offerings .   Currently, there is no cure for polycystic ovary syndrome (PCOS / PCOD), however the affiliated symptoms can be treated using a combination of different types of medications, including insulin-sensitizing agents, oral contraceptives, anti-androgens and anti-obesity drugs. The research activities, including clinical investigations in this domain are being driven by both industry and non-industry players.   To order this 90+ page report, which features 70+ figures, please visit https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html         ...
Read more